Episode 322 ASCO24: The role of ctDNA in the TheraP trial (LuPSMA vs cabazitaxel in CRPC)

The Uromigos - Podcast autorstwa The Uromigos

Podcast artwork

Alex Wyatt describes the predictive resistance of ctDNA fraction at baseline in predicting outcome.

Visit the podcast's native language site